Anaes · Neuromuscular blockade & reversal
Neuromuscular monitoring and the train-of-four
Also known as Train-of-four (TOF) monitoring · Peripheral nerve stimulation · Quantitative neuromuscular monitoring · Acceleromyography · Post-tetanic count
Neuromuscular monitoring is the objective assessment of the depth and recovery of a neuromuscular block by delivering a supramaximal electrical stimulus to a peripheral motor nerve and observing the evoked muscle response. The train-of-four — four stimuli at 2 Hz, 0.5 seconds apart — is the workhorse pattern: it yields a TOF count (the number of detectable twitches, 0 to 4) and a TOF ratio (T4 divided by T1). A non-depolarising block shows fade (ratio below 1.0, with sequential loss of T4 then T3 then T2 then T1) whereas a depolarising phase I block shows no fade (all four twitches reduced proportionally, ratio near 1.0). Residual neuromuscular blockade, defined as a TOF ratio below 0.9 at extubation, is the principal preventable cause of postoperative airway obstruction, aspiration and hypoxia; the 2023 ASA practice guideline mandates quantitative monitoring whenever a neuromuscular blocker is administered, and a confirmed TOF ratio of at least 0.9 before extubation.
Practise this topic
On this page & tools
Your progress
Saved locally on this device.
18 MCQs with explanations
Target exams
Red flags
Meet the patient
A 60-year-old woman is extubated after a three-hour abdominal operation. She obeys commands, opens her eyes, and lifts her head for five seconds. The felt TOF count is 4 with no perceptible fade. Three minutes later she obstructs, desaturates, and needs reintubation. Her true TOF ratio was 0.6.[1]
The dangerous range of residual blockade — a TOF ratio of 0.4 to 0.9 — is precisely the range the human eye and finger cannot perceive. The entire apparatus of monitoring exists to close that blind spot. Hold one principle: the monitor decides, not the eye.[1][14]
You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Anaesthesia fellowship atlas.
References18Show ledgerHide ledger
- [1]Renew JR, et al. The Impact of the 2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade on Quantitative Neuromuscular Monitoring Two Years Later Anesth Analg, 2026.PMID 42361319
- [2]Tao JC, et al. Current status of neuromuscular reversal and neuromuscular monitoring in China: a cross-sectional survey BMC Anesthesiol, 2026.PMID 42185770
- [3]Krönauer T, et al. [Muscle relaxation and neuromuscular monitoring : Current findings and recommendations for the clinical practice] Anaesthesiologie, 2026.PMID 42334564
- [4]Felix F, et al. Recurarization in the Post-anesthesia Care Unit One Hour After Sugammadex Administration: A Case Report Cureus, 2026.PMID 42306367
- [5]Jia X, et al. Sugammadex Vs. Neostigmine for Cerebral Perfusion During Emergence From General Anesthesia in Patients Undergoing Carotid Endarterectomy: A Double-Blind Randomized Controlled Trial CNS Neurosci Ther, 2026.PMID 42144995
- [6]Chen Z, et al. Half-dose neostigmine and low dose sugammadex as a reversal agent for vecuronium: a pilot randomized trial Anaesth Crit Care Pain Med, 2026.PMID 42217574
- [7]Leslie K, et al. Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (SNaPP): an international, randomised, controlled, phase 4 trial Lancet Respir Med, 2026.PMID 42263720
- [8]Blobner M, et al. Use of a train-of-four ratio of 0.95 versus 0.9 for tracheal extubation: an exploratory analysis of POPULAR data Br J Anaesth, 2020.PMID 31607388
- [9]Kirmeier E, et al. Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study Lancet Respir Med, 2019.PMID 30224322
- [10]Savarese JJ, Ali HH, Murphy JD, et al. Train-of-four nerve stimulation in the management of prolonged neuromuscular blockade following succinylcholine Anesthesiology, 1975.PMID 122883
- [11]Eriksson LI Reduced hypoxic chemosensitivity in partially paralysed man. A new property of muscle relaxants? Acta Anaesthesiol Scand, 1996.PMID 8792879
- [12]Wyon N, Joensen H, Yamamoto Y, Lindahl SG, Eriksson LI Carotid body chemoreceptor function is impaired by vecuronium during hypoxia Anesthesiology, 1998.PMID 9856722
- [13]Sundman E, Witt H, Olsson R, Ekberg O, Kuylenstierna R, Eriksson LI The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: pharyngeal videoradiography and simultaneous manometry after atracurium Anesthesiology, 2000.PMID 10754616
- [14]Brull SJ, Silverman DG Visual and tactile assessment of neuromuscular fade Anesth Analg, 1993.PMID 8394051
- [15]Brull SJ, Silverman DG Visual assessment of train-of-four and double burst-induced fade at submaximal stimulating currents Anesth Analg, 1991.PMID 1952146
- [16]Drenck NE, Ueda N, Olsen NV, Engbaek J, Jensen E, Skovgaard LT, Viby-Mogensen J Manual evaluation of residual curarization using double burst stimulation: a comparison with train-of-four Anesthesiology, 1989.PMID 2929994
- [17]Cammu G, Schepens T, De Neve N, et al. Diaphragmatic and intercostal electromyographic activity during neostigmine, sugammadex and neostigmine-sugammadex-enhanced recovery after neuromuscular blockade: A randomised controlled volunteer study Eur J Anaesthesiol, 2017.PMID 27902641
- [18]Fuchs-Buder T, et al. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents III: The 2023 Geneva revision Acta Anaesthesiol Scand, 2023.PMID 37345870